Molecular and immunophenotypic profiling of leukemia cutis in acute myeloid leukemia: A retrospective matched-cohort study - 18/09/25

Abstract |
Background |
Leukemia cutis (LC) is a rare complication of acute myeloid leukemia (AML) and considered a marker of poor prognosis. Molecular and immunophenotypic characteristics of LC remain poorly understood.
Objective |
To investigate molecular and immunophenotypic profiles of AML patients with LC and compare them with AML patients without LC.
Methods |
This retrospective matched-cohort study examined 47 AML patients with LC propensity-matched to 141 AML patients without LC. Frequency of mutations, overall survival, and biomarker concordance between skin and bone marrow samples were analyzed and compared.
Results |
LC patients showed significant enrichment in mutations including NPM1, FLT3, Trisomy/Gain 8, and NRAS/KRAS. Median overall survival for LC patients was 14.6 months, compared to 23.0 months for AML patients without LC. This difference was not statistically significant, and there were no significant differences when comparing across mutation subgroups. Immunophenotypically, high rates of discordance between skin and bone marrow were observed in CD34 and CD117.
Limitations |
Single-center study, limited sample size, and potential unadjusted covariates.
Conclusion |
The results show enrichment of key mutations and loss of biomarker expression in AML-associated LC without differences in overall survival. This distinct molecular and immunophenotypic profile of LC may have important pathogenic, diagnostic, and prognostic implications.
Le texte complet de cet article est disponible en PDF.Key words : acute myeloid leukemia, genotype, immunophenotype, leukemia cutis, molecular, mutation
Abbreviations used : AML, IHC, LC
Plan
| Funding sources: None. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: This study was approved by the Northwestern University Feinberg School of Medicine and Ann & Robert H. Lurie Children's Hospital of Chicago Institutional Review Boards. |
|
| Cuong V. Nguyen had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. |
Vol 93 - N° 4
P. 988-992 - octobre 2025 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
